Update for DIA Europe 2020 : As a direct result of the outbreak of the coronavirus disease, we inform you that DIA has decided to postpone DIA Europe 2020 in Brussels, to june 30 - July 3, 2020. More informations…

BlueReg Team will attend the Dia Europe in Brussels, from  March 17 to 19. Our experts would be there to discuss about your needs concerning Pharmaceutical Development, Regulatory Support, Project Management, CMC, Publishing, Scientific Writing... BlueReg, Nothing But Blue Skies.…

The purpose of the Bill is to replace the EU Human Medicines Directive, which will expire in 2021 at the end of the transition period agreed between the UK and EU   The Bill will collate the existing regulatory powers…

During the summer 2018, authorities become aware of the presence of some nitrosamines in API – ( – presence of N- nitrosodimethylamine (NDMA) - other sartans – presence of N-nitrosodiethylamine NDEA).  Nitrosamines are chemical compounds classified as probable human carcinogens…